- vTv Therapeutics (NASDAQ:VTVT) announced on Monday the appointment of Michael Tung as executive vice president and chief financial officer, effective immediately.
- This executive appointment comes at an important time for the company, which recently reinitiated screening in its CATT1 Phase 3 trial